365253
InSolution™ Gö 6976
Go 6976, Solution, 12-(2-Cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole
| Product information | |||
|---|---|---|---|
| Form | Liquid | ||
| Formulation | A 500 µg/ml solution of Gö 6976 (Cat. No. 365250) in anhydrous DMSO. | ||
| Primary Target | PKC | ||
| Primary Target IC50 | 7.9 nM | ||
| Secondary target | Ca2+-dependent PKC α-isozyme (IC50 = 2.3 nM) and PKCβI (IC50 = 6.2 nM) | ||
| Molar mass | 378.4 | ||
| Protect from Light | Yes | ||
| Packaged under inert gas | Yes | ||
| Cell permeable | Yes | ||
| Purity | ≥95% by HPLC | ||
| Chemical formula | C24H18N4O | ||
| CAS number | 136194-77-9 | ||
| Declaration | Sold under license of U.S. Patent 5,489,608 and European Patent 0,434,057. | ||
| Store and ship information | |||
|---|---|---|---|
| Storage | -20°C | ||
| Ship |
Blue or Dry Ice
Irritant |
||
| Safety information | |||
|---|---|---|---|
| S Phrase |
S: 26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. |
||
| R Phrase |
R: 36/38 |
||
